| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.996 | 0.001 | 0.996 | Spasmolytic | 0.907 0.003 DBMET01508 0.928 0.003 DBMET01509 0.689 0.007 DBMET01510 | ||
| 0.948 | 0.004 | 0.969 | Toll-Like receptor agonist | 0.969 0.003 DBMET01508 0.926 0.004 DBMET01509 0.962 0.004 DBMET01510 | DBMET01508 | |
| 0.947 | 0.004 | 0.968 | Toll-Like receptor 7 agonist | 0.968 0.003 DBMET01508 0.926 0.004 DBMET01509 0.961 0.004 DBMET01510 | DBMET01508 | |
| 0.912 | 0.002 | 0.912 | Cholinergic antagonist | 0.699 0.003 DBMET01508 0.686 0.003 DBMET01509 0.491 0.005 DBMET01510 | ||
| 0.895 | 0.002 | 0.895 | Acetylcholine antagonist | 0.687 0.003 DBMET01508 0.648 0.004 DBMET01509 0.475 0.005 DBMET01510 | ||
| 0.874 | 0.003 | 0.92 | Bronchodilator | 0.92 0.003 DBMET01508 0.613 0.004 DBMET01509 0.606 0.004 DBMET01510 | DBMET01508 | |
| 0.866 | 0.002 | 0.866 | Acetylcholine muscarinic antagonist | 0.608 0.003 DBMET01508 0.581 0.003 DBMET01509 0.422 0.004 DBMET01510 | ||
| 0.826 | 0.002 | 0.826 | Acetylcholine M1 receptor antagonist | 0.593 0.003 DBMET01508 0.544 0.004 DBMET01509 0.34 0.009 DBMET01510 | ||
| 0.814 | 0.004 | 0.814 | Psychostimulant | 0.704 0.004 DBMET01508 0.54 0.008 DBMET01509 0.405 0.022 DBMET01510 | ||
| 0.774 | 0.002 | 0.774 | Acetylcholine nicotinic antagonist | 0.537 0.004 DBMET01508 0.412 0.005 DBMET01509 0.192 0.013 DBMET01510 | ||
| 0.635 | 0.002 | 0.635 | Acetylcholine M3 receptor antagonist | 0.42 0.003 DBMET01508 0.365 0.003 DBMET01509 0.261 0.005 DBMET01510 | ||
| 0.574 | 0.003 | 0.574 | Acetylcholine M4 receptor antagonist | 0.264 0.004 DBMET01508 0.187 0.007 DBMET01509 0.108 0.023 DBMET01510 | ||
| 0.529 | 0.003 | 0.529 | Acetylcholine M2 receptor antagonist | 0.284 0.005 DBMET01508 0.224 0.005 DBMET01509 0.136 0.013 DBMET01510 | ||
| 0.448 | 0.021 | 0.448 | Cardiotonic | 0.282 0.064 DBMET01508 0.242 0.088 DBMET01509 | ||
| 0.389 | 0.02 | 0.389 | Sodium/bile acid cotransporter inhibitor | 0.317 0.065 DBMET01508 0.201 0.186 DBMET01510 | ||
| 0.368 | 0.029 | 0.552 | Vasodilator | 0.552 0.008 DBMET01508 0.447 0.017 DBMET01509 | DBMET01508 | |
| 0.391 | 0.051 | 0.42 | Cholesterol antagonist | 0.42 0.045 DBMET01508 0.387 0.052 DBMET01509 0.329 0.074 DBMET01510 | DBMET01508 | |
| 0.393 | 0.115 | 0.62 | Caspase 9 stimulant | 0.62 0.033 DBMET01508 0.44 0.088 DBMET01509 0.528 0.05 DBMET01510 | DBMET01508 | |
| 0.286 | 0.014 | 0.288 | Anesthetic local | 0.288 0.014 DBMET01508 0.251 0.02 DBMET01509 0.135 0.057 DBMET01510 | DBMET01508 | |
| 0.256 | 0.004 | 0.256 | Acetylcholine M5 receptor antagonist | 0.14 0.009 DBMET01508 0.074 0.028 DBMET01509 0.057 0.047 DBMET01510 | ||
| 0.283 | 0.032 | 0.283 | P-glycoprotein inhibitor | 0.145 0.125 DBMET01508 0.153 0.113 DBMET01509 | ||
| 0.266 | 0.025 | 0.266 | Cytidine deaminase inhibitor | 0.205 0.045 DBMET01508 0.151 0.074 DBMET01509 | ||
| 0.317 | 0.078 | 0.317 | Antithrombotic | 0.291 0.094 DBMET01508 0.231 0.142 DBMET01509 | ||
| 0.301 | 0.094 | 0.301 | Transcription factor NF kappa B inhibitor | 0.255 0.124 DBMET01509 | ||
| 0.258 | 0.054 | 0.258 | Anticonvulsant | |||
| 0.299 | 0.116 | 0.367 | Immunosuppressant | 0.302 0.113 DBMET01508 0.367 0.078 DBMET01510 | DBMET01510 | |
| 0.187 | 0.005 | 0.187 | Dopamine D5 antagonist | 0.069 0.015 DBMET01508 | ||
| 0.202 | 0.02 | 0.202 | Expectorant | 0.189 0.023 DBMET01508 0.154 0.034 DBMET01509 0.095 0.074 DBMET01510 | ||
| 0.225 | 0.059 | 0.25 | Platelet adhesion inhibitor | 0.139 0.119 DBMET01508 0.25 0.049 DBMET01509 | DBMET01509 | |
| 0.189 | 0.023 | 0.189 | Cyclooxygenase 3 inhibitor | |||
| 0.258 | 0.093 | 0.375 | Immunostimulant | 0.375 0.057 DBMET01508 0.306 0.077 DBMET01509 0.277 0.086 DBMET01510 | DBMET01508 | |
| 0.3 | 0.135 | 0.364 | Antibacterial | 0.364 0.094 DBMET01508 0.363 0.095 DBMET01509 0.305 0.132 DBMET01510 | DBMET01508 | |
| 0.239 | 0.075 | 0.239 | Angiogenesis stimulant | 0.184 0.103 DBMET01508 | ||
| 0.182 | 0.018 | 0.182 | Mucolytic | 0.173 0.022 DBMET01508 0.148 0.033 DBMET01509 0.099 0.08 DBMET01510 | ||
| 0.17 | 0.013 | 0.188 | Ca2+-transporting ATPase inhibitor | 0.188 0.005 DBMET01508 0.157 0.029 DBMET01509 0.177 0.008 DBMET01510 | DBMET01508 | |
| 0.265 | 0.119 | 0.317 | Vasodilator, coronary | 0.317 0.074 DBMET01508 | DBMET01508 | |
| 0.292 | 0.148 | 0.292 | Analgesic | |||
| 0.252 | 0.116 | 0.331 | Interleukin 2 agonist | 0.331 0.055 DBMET01508 0.247 0.122 DBMET01510 | DBMET01508 | |
| 0.22 | 0.088 | 0.22 | Platelet antagonist | 0.175 0.121 DBMET01508 0.171 0.125 DBMET01509 | ||
| 0.149 | 0.02 | 0.157 | Acetylcholine M3 receptor agonist | 0.157 0.016 DBMET01508 0.156 0.016 DBMET01509 0.122 0.034 DBMET01510 | DBMET01508 | |
| 0.158 | 0.03 | 0.158 | Antihistaminic | 0.103 0.053 DBMET01508 | ||
| 0.145 | 0.024 | 0.145 | Toll-Like receptor 4 antagonist | 0.109 0.056 DBMET01508 0.111 0.054 DBMET01509 | ||
| 0.205 | 0.09 | 0.205 | Hypolipemic | |||
| 0.12 | 0.011 | 0.12 | Acetylcholine M5 receptor agonist | 0.079 0.035 DBMET01508 | ||
| 0.137 | 0.033 | 0.137 | Histamine antagonist | 0.088 0.056 DBMET01508 | ||
| 0.161 | 0.061 | 0.161 | Lipid peroxidase inhibitor | |||
| 0.166 | 0.069 | 0.195 | Arachidonic acid antagonist | 0.195 0.038 DBMET01508 0.176 0.058 DBMET01510 | DBMET01508 | |
| 0.115 | 0.019 | 0.115 | Neuronal nicotinic receptor antagonist | 0.11 0.02 DBMET01508 | ||
| 0.17 | 0.08 | 0.17 | Lipocortins synthesis antagonist | 0.14 0.121 DBMET01508 | ||
| 0.106 | 0.016 | 0.106 | Acetylcholine muscarinic agonist | 0.106 0.016 DBMET01508 0.059 0.035 DBMET01510 | ||
| 0.194 | 0.107 | 0.256 | Peptidyltransferase inhibitor | 0.256 0.047 DBMET01508 0.201 0.098 DBMET01510 | DBMET01508 | |
| 0.163 | 0.082 | 0.198 | Phospholipase C inhibitor | 0.198 0.045 DBMET01508 0.17 0.073 DBMET01510 | DBMET01508 | |
| 0.211 | 0.133 | 0.228 | Gastrin inhibitor | 0.228 0.107 DBMET01508 0.19 0.164 DBMET01509 | DBMET01508 | |
| 0.108 | 0.03 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET01508 0.115 0.023 DBMET01510 | DBMET01510 | |
| 0.098 | 0.022 | 0.132 | Glycine receptor agonist | 0.132 0.01 DBMET01508 0.108 0.017 DBMET01510 | DBMET01508 | |
| 0.152 | 0.075 | 0.181 | Cholinergic | 0.181 0.056 DBMET01508 0.13 0.096 DBMET01510 | DBMET01508 | |
| 0.209 | 0.135 | 0.379 | 5 Hydroxytryptamine uptake stimulant | 0.379 0.018 DBMET01508 0.346 0.027 DBMET01509 0.267 0.066 DBMET01510 | DBMET01508 | |
| 0.08 | 0.009 | 0.08 | Beta 2 adrenoreceptor agonist | 0.073 0.014 DBMET01508 | ||
| 0.137 | 0.078 | 0.172 | Protein kinase stimulant | 0.172 0.054 DBMET01508 0.121 0.091 DBMET01509 0.132 0.082 DBMET01510 | DBMET01508 | |
| 0.136 | 0.079 | 0.186 | Cell wall synthesis inhibitor | 0.186 0.036 DBMET01508 0.114 0.109 DBMET01509 | DBMET01508 | |
| 0.147 | 0.098 | 0.179 | Nitric oxide antagonist | 0.179 0.077 DBMET01509 | DBMET01509 | |
| 0.21 | 0.165 | 0.291 | Vasodilator, peripheral | 0.291 0.102 DBMET01508 0.198 0.179 DBMET01510 | DBMET01508 | |
| 0.12 | 0.078 | 0.128 | Acetylcholinesterase inhibitor | 0.128 0.071 DBMET01508 | DBMET01508 | |
| 0.152 | 0.112 | 0.294 | Anesthetic general | 0.294 0.034 DBMET01508 | DBMET01508 | |
| 0.252 | 0.212 | 0.345 | Apoptosis agonist | 0.24 0.226 DBMET01508 0.345 0.142 DBMET01509 | DBMET01509 | |
| 0.136 | 0.099 | 0.187 | Interferon gamma antagonist | 0.187 0.046 DBMET01508 0.138 0.095 DBMET01510 | DBMET01508 | |
| 0.095 | 0.06 | 0.143 | Prolactin inhibitor | 0.143 0.025 DBMET01508 0.112 0.045 DBMET01510 | DBMET01508 | |
| 0.107 | 0.078 | 0.107 | Cholesterol synthesis inhibitor | 0.103 0.084 DBMET01508 | ||
| 0.086 | 0.058 | 0.243 | Antineoplastic alkaloid | 0.166 0.023 DBMET01508 0.093 0.053 DBMET01509 0.243 0.005 DBMET01510 | DBMET01510 | |
| 0.086 | 0.059 | 0.099 | Acetylcholine agonist | 0.099 0.047 DBMET01508 | DBMET01508 | |
| 0.094 | 0.067 | 0.155 | Sphingomyelinase inhibitor | 0.155 0.023 DBMET01508 0.095 0.065 DBMET01510 | DBMET01508 | |
| 0.075 | 0.054 | 0.075 | Analgesic, opioid | 0.073 0.057 DBMET01508 0.074 0.056 DBMET01510 | ||
| 0.05 | 0.032 | 0.088 | Nicotinic receptor alpha4 subunit antagonist | 0.088 0.011 DBMET01508 0.054 0.027 DBMET01509 | DBMET01508 | |
| 0.108 | 0.091 | 0.247 | Alpha-N-acetylglucosaminidase inhibitor | 0.247 0.023 DBMET01508 0.192 0.037 DBMET01510 | DBMET01508 | |
| 0.05 | 0.038 | 0.099 | 5 Hydroxytryptamine 4 antagonist | 0.099 0.007 DBMET01508 | DBMET01508 | |
| 0.051 | 0.043 | 0.095 | Alpha-mannosidase inhibitor | 0.095 0.007 DBMET01508 0.079 0.012 DBMET01510 | DBMET01508 | |
| 0.045 | 0.037 | 0.071 | Dopamine transporter inhibitor | 0.071 0.02 DBMET01508 0.05 0.032 DBMET01509 | DBMET01508 | |
| 0.055 | 0.048 | 0.058 | Lipocortins synthesis agonist | 0.058 0.041 DBMET01508 0.055 0.05 DBMET01510 | DBMET01508 | |
| 0.134 | 0.128 | 0.178 | Hepatoprotectant | 0.178 0.082 DBMET01508 0.166 0.093 DBMET01509 | DBMET01508 | |
| 0.027 | 0.023 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.008 DBMET01508 0.028 0.022 DBMET01509 | DBMET01508 | |
| 0.05 | 0.058 | 0.055 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.042 DBMET01508 | DBMET01508 | |
| 0.044 | 0.055 | 0.058 | Acetylcholine M2 receptor agonist | 0.058 0.031 DBMET01508 | DBMET01508 | |
| 0.06 | 0.073 | 0.084 | Antineoplastic antibiotic | 0.084 0.055 DBMET01508 0.08 0.057 DBMET01510 | DBMET01508 | |
| 0.077 | 0.092 | 0.186 | Creatine kinase inhibitor | 0.186 0.013 DBMET01508 0.151 0.024 DBMET01510 | DBMET01508 | |
| 0.065 | 0.08 | 0.072 | Adrenaline agonist | 0.072 0.069 DBMET01508 | DBMET01508 | |
| 0.036 | 0.051 | 0.05 | Microtubule stabilization | 0.05 0.028 DBMET01510 | DBMET01510 | |
| 0.115 | 0.13 | 0.169 | Growth hormone agonist | 0.169 0.074 DBMET01509 | DBMET01509 | |
| 0.05 | 0.066 | 0.059 | Dopamine D1 antagonist | 0.059 0.051 DBMET01508 | DBMET01508 | |
| 0.088 | 0.104 | 0.158 | Alkylator | 0.158 0.043 DBMET01508 | DBMET01508 | |
| 0.084 | 0.105 | 0.097 | DNA polymerase I inhibitor | 0.097 0.09 DBMET01508 | DBMET01508 | |
| 0.037 | 0.059 | 0.064 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DBMET01508 0.064 0.028 DBMET01510 | DBMET01510 | |
| 0.079 | 0.101 | 0.131 | Anabolic | 0.131 0.03 DBMET01508 0.099 0.064 DBMET01509 0.1 0.062 DBMET01510 | DBMET01508 | |
| 0.033 | 0.056 | 0.075 | Mannosidase inhibitor | 0.075 0.01 DBMET01508 0.06 0.017 DBMET01510 | DBMET01508 | |
| 0.017 | 0.057 | 0.028 | 5 Hydroxytryptamine 4 agonist | 0.028 0.009 DBMET01508 | DBMET01508 | |
| 0.011 | 0.055 | 0.027 | RNA-directed RNA polymerase stimulant | 0.027 0.023 DBMET01508 | DBMET01508 | |
| 0.123 | 0.172 | 0.147 | Succinate dehydrogenase inhibitor | 0.147 0.118 DBMET01508 | DBMET01508 | |
| 0.032 | 0.085 | 0.061 | Dopamine uptake inhibitor | 0.061 0.037 DBMET01508 | DBMET01508 | |
| 0.141 | 0.199 | 0.4 | 5 Hydroxytryptamine release stimulant | 0.394 0.047 DBMET01508 0.4 0.046 DBMET01509 0.266 0.082 DBMET01510 | DBMET01509 | |
| 0.032 | 0.09 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.027 DBMET01508 0.045 0.039 DBMET01510 | DBMET01508 | |
| 0.047 | 0.108 | 0.11 | Nicotinic alpha4beta2 receptor antagonist | 0.11 0.023 DBMET01508 0.102 0.03 DBMET01509 | DBMET01508 | |
| 0.169 | 0.233 | 0.207 | Apoptosis antagonist | 0.207 0.17 DBMET01508 | DBMET01508 | |
| 0.022 | 0.088 | 0.033 | Tubulin agonist | 0.033 0.026 DBMET01508 | DBMET01508 | |
| 0.053 | 0.119 | 0.083 | Interferon agonist | 0.083 0.047 DBMET01508 | DBMET01508 | |
| 0.108 | 0.177 | 0.193 | Interleukin 6 antagonist | 0.193 0.045 DBMET01509 | DBMET01509 | |
| 0.008 | 0.086 | 0.034 | Squalene synthetase inhibitor | 0.034 0.021 DBMET01509 | DBMET01509 | |
| 0.019 | 0.098 | 0.047 | Ceramide glucosyltransferase inhibitor | 0.047 0.009 DBMET01508 0.033 0.029 DBMET01510 | DBMET01508 | |
| 0.031 | 0.113 | 0.083 | Phosphofructokinase-1 inhibitor | 0.083 0.039 DBMET01508 0.061 0.055 DBMET01510 | DBMET01508 | |
| 0.071 | 0.154 | 0.121 | Microtubule formation inhibitor | 0.11 0.074 DBMET01508 0.121 0.059 DBMET01510 | DBMET01510 | |
| 0.049 | 0.133 | 0.115 | Glycine receptor antagonist | 0.115 0.021 DBMET01508 0.093 0.039 DBMET01510 | DBMET01508 | |
| 0.063 | 0.148 | 0.104 | Adenylate cyclase inhibitor | 0.104 0.081 DBMET01508 | DBMET01508 | |
| 0.013 | 0.103 | 0.028 | Vanilloid 2 agonist | 0.028 0.013 DBMET01508 0.024 0.021 DBMET01510 | DBMET01508 | |
| 0.048 | 0.141 | 0.062 | Prolactin release inhibitor | 0.062 0.045 DBMET01508 | DBMET01508 | |
| 0.023 | 0.116 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 DBMET01508 | DBMET01508 | |
| 0.036 | 0.131 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 DBMET01508 | DBMET01508 | |
| 0.096 | 0.193 | 0.154 | Adenylate cyclase stimulant | 0.154 0.056 DBMET01508 0.136 0.09 DBMET01510 | DBMET01508 | |
| 0.049 | 0.146 | 0.093 | Opioid kappa receptor antagonist | 0.093 0.043 DBMET01508 0.073 0.07 DBMET01509 | DBMET01508 | |
| 0.034 | 0.132 | 0.096 | Glucosylceramidase inhibitor | 0.096 0.009 DBMET01508 0.07 0.022 DBMET01510 | DBMET01508 | |
| 0.027 | 0.127 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.036 DBMET01508 | DBMET01508 | |
| 0.109 | 0.21 | 0.149 | ATPase inhibitor | 0.149 0.103 DBMET01508 | DBMET01508 | |
| 0.017 | 0.118 | 0.039 | Opioid kappa receptor agonist | 0.039 0.036 DBMET01508 | DBMET01508 | |
| 0.029 | 0.148 | 0.097 | Sphingosine kinase 2 inhibitor | 0.097 0.008 DBMET01508 | DBMET01508 | |
| 0.098 | 0.217 | 0.262 | Interleukin agonist | 0.262 0.07 DBMET01508 | DBMET01508 | |
| 0.145 | 0.27 | 0.218 | Tyrosine 3 hydroxylase inhibitor | 0.218 0.106 DBMET01508 0.188 0.159 DBMET01510 | DBMET01508 | |
| 0.023 | 0.152 | 0.07 | Carbamoyl phosphate synthetase inhibitor | 0.07 0.034 DBMET01508 0.054 0.049 DBMET01510 | DBMET01508 | |
| 0.026 | 0.157 | 0.07 | Androgen agonist | 0.07 0.031 DBMET01508 | DBMET01508 | |
| 0.074 | 0.206 | 0.113 | Neurotrophic factor | 0.113 0.108 DBMET01508 | DBMET01508 | |
| 0.038 | 0.171 | 0.099 | Telomerase inhibitor | 0.099 0.034 DBMET01508 | DBMET01508 | |
| 0.033 | 0.166 | 0.091 | Phospholipase D inhibitor | 0.091 0.021 DBMET01508 | DBMET01508 | |
| 0.01 | 0.148 | 0.042 | Acetylcholine M1 receptor agonist | 0.042 0.031 DBMET01508 | DBMET01508 | |
| 0.019 | 0.158 | 0.07 | Acyl-CoA dehydrogenase inhibitor | 0.07 0.027 DBMET01508 0.053 0.04 DBMET01510 | DBMET01508 | |
| 0.029 | 0.169 | 0.084 | Sphingosine kinase inhibitor | 0.084 0.014 DBMET01508 | DBMET01508 | |
| 0.029 | 0.17 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.036 DBMET01508 | DBMET01508 | |
| 0.195 | 0.341 | 0.381 | Antiinflammatory | 0.381 0.151 DBMET01509 | DBMET01509 | |
| 0.032 | 0.178 | 0.057 | Potassium channel (Ca-activated) blocker | 0.057 0.047 DBMET01508 | DBMET01508 | |
| 0.123 | 0.269 | 0.261 | DNA synthesis inhibitor | 0.261 0.06 DBMET01508 0.198 0.127 DBMET01510 | DBMET01508 | |
| 0.098 | 0.246 | 0.188 | Neurotrophic factor enhancer | 0.188 0.09 DBMET01508 0.153 0.134 DBMET01510 | DBMET01508 | |
| 0.087 | 0.238 | 0.193 | Aldehyde oxidase inhibitor | 0.193 0.108 DBMET01508 | DBMET01508 | |
| 0.022 | 0.181 | 0.039 | Kainate receptor agonist | 0.039 0.034 DBMET01508 | DBMET01508 | |
| 0.019 | 0.184 | 0.038 | Thymidine kinase inhibitor | 0.038 0.033 DBMET01508 | DBMET01508 | |
| 0.087 | 0.253 | 0.18 | Antipruritic | 0.18 0.064 DBMET01508 | DBMET01508 | |
| 0.044 | 0.213 | 0.093 | UDP-glucose 4-epimerase inhibitor | 0.093 0.069 DBMET01508 | DBMET01508 | |
| 0.015 | 0.184 | 0.049 | Adenosine deaminase inhibitor | 0.049 0.031 DBMET01508 | DBMET01508 | |
| 0.03 | 0.203 | 0.068 | Alpha 1L adrenoreceptor antagonist | 0.068 0.014 DBMET01510 | DBMET01510 | |
| 0.017 | 0.193 | 0.055 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET01508 | DBMET01508 | |
| 0.017 | 0.198 | 0.051 | Argininosuccinate synthase inhibitor | 0.051 0.046 DBMET01508 | DBMET01508 | |
| 0.015 | 0.226 | 0.047 | Sphingosine kinase 1 inhibitor | 0.047 0.019 DBMET01508 | DBMET01508 | |
| 0.053 | 0.282 | 0.105 | Adenylate kinase inhibitor | 0.105 0.06 DBMET01508 | DBMET01508 | |
| 0.038 | 0.27 | 0.111 | GABA C receptor antagonist | 0.111 0.063 DBMET01508 | DBMET01508 | |
| 0.014 | 0.252 | 0.029 | Hedgehog signaling activator | 0.029 0.015 DBMET01508 | DBMET01508 | |
| 0.039 | 0.301 | 0.085 | NADH dehydrogenase inhibitor | 0.085 0.065 DBMET01508 | DBMET01508 | |
| 0.04 | 0.311 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.063 DBMET01508 | DBMET01508 | |
| 0.075 | 0.471 | 0.168 | RNA-directed DNA polymerase inhibitor | 0.168 0.157 DBMET01508 | DBMET01508 | |
| 0.083 | 0.484 | 0.27 | GABA C receptor rho-3 antagonist | 0.27 0.138 DBMET01508 0.206 0.2 DBMET01510 | DBMET01508 | |
| 0.004 | 0.475 | 0.026 | Purinergic P2Y15 antagonist | 0.026 0.025 DBMET01508 | DBMET01508 | |
| 0.028 | 0.527 | 0.11 | mTOR complex 1 inhibitor | 0.11 0.043 DBMET01510 | DBMET01510 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |